Reliable differentiation of tumor recurrence and treatment effects in glioblastoma patients is still a prevailing challenge. The purpose of this study is to identify the optimal threshold for generating fractional tumor burden (FTB) maps derived from single-dose, dual-echo based standardized relative cerebral blood volume measurements. To establish the threshold, dual-echo data was compared to the well-validated, double-dose single echo standardized FTB map. In summary, with the optimized threshold, the single-dose, dual-echo approach yielded FTB maps that strongly agreed with the reference standard, providing a compelling option for clinical use.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords